A Louisiana law kicking in during August could open the door for a lot more people to use medical marijuana. Restrictions on prescribing doctors and ailments have been lifted.
At the capitol Wednesday, May 13, Louisiana lawmakers moved ahead with a proposal to allow doctors to recommend medical marijuana for people who suffer from fibromyalgia.
Louisiana’s sickest patients now have access to a pair of new medical marijuana products that are essentially twice as strong as the medicine that’s been available since the program began in August.
Southern University has become the first Historically Black College University (HBCU) to launch a hemp product line. The school’s agricultural research and extension center in Baton Rouge has partnered with Ilera Holistic Healthcare to deliver CBD to dispensaries in Louisiana.
Farmers could begin growing industrial hemp by the spring of 2020 if the state and federal departments of agriculture continue to hammer out logistics at their current pace, Louisiana Department of Agriculture and Forestry (LDAF) Commissioner Mike Strain said Monday, Oct. 21.
The need for medicinal marijuana isn’t going away. In fact, the industry is literally growing and the once hazy hesitation to jump into the business could be changing for good.
Suffering with chronic pain after some major surgeries, Jackie Hyer was excited for some relief from her new medical marijuana prescription, and she says it worked. What she didn't anticipate was the price.
When medical marijuana became available on Aug. 6, Alex Domino said he had no expectations. For him, the medicine was simply a remedy for a myriad of serious ailments that he had not tried.
Certain physicians in Louisiana will soon be able to recommend medical marijuana as a treatment option for patients who qualify. Here’s what residents hoping to seek products need to know.
On Thursday, Aug. 1, the Louisiana Department of Agriculture and Forestry (LDAF) announced it has completed testing on the first batch of medical marijuana produced by LSU’s sub-contractor, GB Sciences.
Dozens of businesses were issued permits on July 15, 2019, by the Louisiana Office of Alcohol and Tobacco Control (ATC) to allow the legal sale of hemp-derived CBD products.
Medical marijuana could finally be available for Louisiana’s sickest patients in “the next few weeks," according to grower, GB Sciences’, Vice President John Davis.
On Monday, June 24, the Louisiana Office of Alcohol and Tobacco Control (ATC) issued its first permits to allow the legal sale of hemp-derived CBD products. Multiple temporary permits were issued, the office says, including five in the Baton Rouge area.
The Louisiana Department of Health (LDH) has announced it will start to begin issuing permits to CBD manufacturers after the sale of such products was made legal with the passage of House Bill 491.
A bill to regulate the growth of industrial hemp is headed to the governor’s desk after winning final legislative approval. It also paves the way for licensed retailers to legally sell hemp-derived products, including CBD oil.
Medical marijuana will soon be available to qualifying patients, despite recent roadblocks to access. The clinic will begin seeing patients Monday, May 20.
Louisiana's medical marijuana patients would be able to inhale cannabis, if senators agree to a proposal that won overwhelming support from lawmakers in the House
Lawmakers have broadened a proposal to legalize the growing of industrial hemp in Louisiana to also create a regulatory framework for CBD product sales
Louisiana's first batch of medical marijuana won't reach the shelves by the mid-May deadline demanded by pharmacists and patients, but June could be a possibility
The Louisiana House’s health committee approved a bill Wednesday, May 1 that would loosen regulations on the state’s medical marijuana program so certain patients could use medical marijuana inhalers.
A number of advocates for medical marijuana celebrated Cannabis Day on Monday, April 22 by asking lawmakers to expand the state’s medical marijuana program.
A group of Louisiana marijuana pharmacists demanded the state have final medicinal product available by May 15 at a stakeholder’s meeting Monday, Mar. 25.
LSU’s AgCenter has released a statement after allegations were made by the Louisiana Department of Agriculture and Forestry (LDAF) that they’re violated the state’s medical marijuana law.
The Louisiana Board of Pharmacy will discuss the amount of THC allowable in a single prescription for medical marijuana, which will determine the price.
While the hype around CBD has exploded over the last couple of years, scientific research is still relatively young. But studies that have been conducted show promising results for a variety of conditions, including anxiety, PTSD, insomnia, and chronic pain.
A judge ruled a lawsuit against the Louisiana Pharmacy Board can move forward. This after a former candidate for a medical marijuana license says the licenses were awarded based on biased decisions.
After more than a year of delays, members of the Southern University Board of Supervisors got down right blunt about a medical marijuana deal they say went sour. They also chose to move ahead with a new firm to manage their growing operations.
Epidiolex is a twice-daily oral solution for patients ages two and older, who suffer from either Dravet syndrome, or Lennox-Gastaut syndrome. (Source: CNN/GW PHARMACEUTICALS)
Researchers at GB Sciences and the LSU AgCenter finished harvesting the state’s first medical marijuana crop Tuesday, but procedural issues could again prevent Louisiana patients from getting access to the medicine in a timely fashion.
The Louisiana State Board of Medical Examiners voted 8 to 1 Monday to begin eliminating the limit on the number of patients for which doctors can recommend therapeutic marijuana.
GB Sciences and the LSU AgCenter began growing medical marijuana inside their southern Baton Rouge facility this week, meaning patients could have access to the finished product by November.
With only a few doctors signing up to dispense medical marijuana, Louisiana regulators are considering whether to change rules limiting how many cannabis patients each doctor can treat.
